BCW Index Starts Second Half Strongly; Millipore Added | GenomeWeb

The BCW Index has started the second half of 2006 strongly with a gain of 3.4 percent for the shortened trading week ended Monday. The Nasdaq Biotech Index outpaced the BCW Index, climbing 5.2 percent, while the Nasdaq gained 4.3 percent, and the Dow Jones Industrial Average rose 2.8 percent. Every stock in the Index gained ground for the tracking period, with Stratagene leading the way with a rise of 12.7 percent. Qiagen and Fisher Scientific both rose more than 6 percent for the week.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.